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Primary pulmonary scar carcinoma with triplicate differentiation is very rare. A 66-year-old woman
presented with cough, and consulted to a private hospital, where she was pointed out to have abnormal
lung shadow by chest X-P. She was admitted to our hospital for scrutiny. Imaging modalities including
chest X-P, CT, and MRI revealed a main tumor (35 mm in diameter) in the right lower lobe and multiple
small metastases in both lungs. Biopsies and cytology revealed an adenocarcinoma. Metastasis to the
liver, iliac bone and tibia bone were also detected. She was diagnosed as stage IV lung adenocarcinoma
(T2N3M1), and received chemotherapy. Soon, she complained of right hemiparesis, and brain CT revealed
multiple brain metastases. She died of respiratory failure due to bronchopneumonia 7 months after
admission. An autopsy revealed a lung tumor (4  4  3 cm) in the right lower lobe. Miliary micro-
metastases were recognized in bilateral lungs, brain, bones, pleura, liver, brain, and systemic lymph
nodes. The lungs showed bronchopneumonia. The liver was cirrhotic. Microscopically, the primary lung
tumor consisted of adenocarcinoma element (70% in area), squamous cell carcinoma element (20%), and
small cell carcinoma element (10%), all of which were embedded in a ﬁbroelastic scar with calciﬁcation
(scar carcinoma). There were gradual merges between the adenocarcinoma and squamous cell carcinoma
elements, but the small cell carcinoma element was isolated. The liver metastases were composed only of
small cell carcinoma, and other metastatic sites consisted of adenocarcinoma, squamous cell carcinoma,
and small cell carcinoma. Other pathologic changes included pulmonary aspergilosis, bronchopneu-
monia, splenomegaly, emphysema, cardiac hypertrophy, and kidney congestion. The present case shows
that a lung scar carcinoma can display triplicate differentiations.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Primary lung cancer may develop in a scar. Such cancer has been
calledbyscarcancer. It is characterizedbyﬁbroelastic scar, deposition
of ducts, and peripheral localization with pleural puckering.1–5 The
scar is formed by atherectasis, infarction, tubercurosis, anthracosis,
and other exogenous agents. Almost all of scar cancers are adeno-
carcinomas. However, pulmonary scar cancers with multiple histo-
logical components have rarely reported, to the best of the author’s
knowledge.
Combined pulmonary combined carcinomas consisting of more
than two histological types have been reported. A review of English
literature revealed 17 case studies of combined lung cancers.6–22rved.However, there have been no cases of combined scar carcinoma of
the lung in the literature. Here, the author reports a case of primary
pulmonary combined scar carcinoma composed of adenocarci-
noma, squamous cell carcinoma, and small cell carcinoma
elements.1.1. Case report
A 66-year-old woman complained of cough, and consulted to
a private hospital, where she was found to have abnormal lung
shadow by chest X-P. She was admitted to our hospital for scrutiny.
Imaging modalities including chest X-P, CT, and MRI revealed
a main tumor (35 mm in diameter) in the right lower lobe and
multiple small metastasis in both lungs. Biopsies and cytology
revealed an adenocarcinoma. Metastasis to the liver, iliac bone and
tibia bone were also detected. She was diagnosed as stage IV lung
adenocarcinoma (T2N3M1), and was treated by chemotherapy.
Fig. 2. Adenocarcinoma element within the scar. HE, x200.
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multiple brain metastases. She died of respiratory failure due to
bronchopneumonia 7 months after admission.
An autopsy revealed a lung tumor (4  4  3 cm) in the right
lower lobe (Fig. 1). The lung tumor was hard, and was heavily
pigmented. The tumor involved the pleura with pleural indenta-
tion. Miliary micrometastases up to 5 mm were recognized in
bilateral lungs, brain, bones, pleura, liver, brain, and systemic lymph
nodes. The lungs showed emphysema, bronchopneumonia, and
mucin impaction. The liver was cirrhotic.
Microscopically, the primary lung tumor consisted of adeno-
carcinoma (Fig. 2) (70% in area), squamous cell carcinoma (Fig. 3)
(20%), and small cell carcinoma elements (Fig. 4) (10%), all of
which were embedded in a scar with calciﬁcation (‘‘scar carci-
noma’’) (Fig. 5). The scar area contained many elastic ﬁbers,
collagen ﬁbers, heavy duct deposition, foci of calciﬁcation, and
pleural involvement (Fig. 5). There were gradual merges between
the adenocarcinoma and squamous cell carcinoma elements
(Fig. 6) in the lung carcinoma. However, the small cell carcinoma
element was isolated, and there were no transitions between the
small cell carcinoma element and the other two elements. The
liver metastases were composed only of small cell carcinoma
(Fig. 7). The other metastatic sites (lungs, brain, bones, pleura,
liver, brain, and lymph nodes) consisted of adenocarcinoma,
squamous cell carcinoma, and small cell carcinoma (Figs. 8 and 9).
In these metastatic sites other than the liver, the adenocarcinoma
element was closely associated with squamous cell carcinoma
elements; gradual merges were noted between the two. In
contrast, small cell carcinoma element in the metastatic sites was
isolated, and there were no associations with the adenocarcinoma
and squamous cell carcinoma elements.
An immunohistochemical study was performed with the use of
Dako Envision method (Dako, Glostrup, Denmark), as described
previously.24,25 The antibodies examined and the results are shown
in Table 1. The adenocarcinoma element was positive for pan-
cytokeratins, CK7, CK8, CK18, CK19, epithelial membrane antigenFig. 1. The primary pulmonary carcinoma of the right lobe. A 4  4  3 cm tumor is
present with pleural involvement. The tumor is very hard and pigmented. The tumor
fulﬁlls the criteria of scar carcinoma.(EMA), CEA (Fig. 10), and PDGFRA. It was negative for CK5/6, CK14,
CK20, TTF-1, PE10, p53 protein, chromogranin, synaptophysin,
CD56, and KIT. The squamous cell carcinoma element was positive
for pancytokeratin, CK5/6 (Fig. 11), CK7, CK8, CK18, CK19, epithelial
membrane antigen (EMA), CEA, and PDGFRA. It was negative for
CK14, CK20, TTF-1, PE10, p53 protein, chromogranin, synaptophy-
sin, CD56, and KIT. The small cell carcinoma was positive for pan-
cytokeratins, CK18 (Fig. 12), chromogranin, synaptophysin (Fig. 13),
CD56, and PDGFRA. It was negative for CK5/6, CK7, CK8, CK14, CK19,
CK20, TTF-1, PE10, EMA, CEA, p53 protein, and KIT. The Ki-67
labeling was 22% in adenocarcinoma elements, 31% in squamous
cell carcinoma element, and 8% in small cell carcinoma element.
Therefore, the immunophenotypes were very similar in adenocar-
cinoma and squamous cell carcinoma elements. The immunophe-
notypes of small cell carcinoma element was entirely different from
those of adenocarcinoma and squamous cell carcinoma elements.
The small cell carcinoma elements showed neuroendocrine
features.
Other pathologic changes included pulmonary multiple asper-
gilosis, pulmonary edema, bronchopneumonia, splenomegaly,
emphysema, cardiac hypertrophy, and kidney congestion. The
cause of death was respiratory failure due to the pulmonary lesions.Fig. 3. Squamous cell carcinoma elemen within the scar. HE, x200.
Fig. 4. Small cell carcinoma element within the scar. HE, x200. Fig. 6. There are merges between adenocarcinoma and squamous cell carcinoma
elements. HE, x200.
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Scar cancer of the lung is an old term. It is rare, and character-
ized by peripheral lung cancer with ﬁbroelastotic scar, pleural
involvement, and pigmentation.1–5 Therefore, the present lung
cancer is categorized as scar cancer. The scar cancer is rare; Auer-
bach et al.1 identiﬁed 82 scar cancers among 1186 lung cancers, the
frequency is 7% of all lung carcinoma. Most of the scar cancer is
adenocarcinoma. For example, Shimosato et al.2 reported that of
the 58 scar cancers, 48 were adenocarcinomas, 2 were large cell
carcinomas, and 8 were squamous cell carcinomas. A review of the
literature, there have been no cases of scar cancers with small cell
carcinoma histologies and combined carcinoma histologies,1–5 to
the best of the author’s knowledge. Therefore, the present case
appears the ﬁrst case of scar cancer with small cell carcinoma
histologies or with combined carcinoma histologies. The patho-
genesis of the scar of scar cancers has been unclear; infarction,
tuberculosis, atherectasis, and anthracosis are proposed.1–5 The
scar of the present is also unclear. It is reported that the epithelium
within the scar harbors loss of heterozygosity (LOH) of tumor
suppressor genes, which may be related to carcinogenesis within
the scar.24 It is probable that the tumor of the present case arose
from such genetically altered epithelium within the scar. It is alsoFig. 5. The pulmonary scar consisting of ﬁbroelastosis. A tubule of adenocarcinoma is
seen in this ﬁleld. HE, x100.possible that the tumor was derived from totipotential stem cells
present in the lung.
In the present case, three components, i.e. adenocarcinoma,
squamous cell carcinoma, and small cell carcinoma, were present in
the pulmonary scar. Histologically, there were close merges
between the adenocarcinoma and squamous cell carcinoma
elements. In addition, immunophenotypes of these two elements
were almost the same except for CK5/6. These ﬁnding strongly
suggest that the adenocarcinoma and squamous cell carcinoma
elements are the same clone. The author speculates that the
squamous cell carcinoma element is derived from squamous
transdifferentiation of adenocarcinoma developed in the scar. In
contrast, the small cell carcinoma element is isolated in the scar,
and there were no merges with the other two elements. The small
cell carcinoma elements had neuroendocrine features. In addition,
immunophenotypes of the small cell carcinoma was entirely
different from those of adenocarcinoma and squamous cell carci-
noma elements. These ﬁndings strongly suggest that the small cell
carcinoma element is a tumor different from the adenocarcinoma
and squamous cell carcinoma. LOH studies of these combined
pulmonary carcinomas are necessary to determine the clonality.
In metastatic sites, there was a close association between the
adenocarcinoma and squamous cell carcinoma elements, while theFig. 7. Liver metastasis is composed only of small cell carcinoma. HE, x200.
Fig. 8. Brain metastasis shows carcinoma tissue with intermixed features of adeno-
carcinoma and squamous cell carcinoma. HE, x200.
Table 1
Immunohistochemical reagents and results.
Antigens Antibodies
(clone)
Sources Adeno Squamous Small
Pancytokeratin AE1/3 Dako Corp. Glostrup,
Denmark
þþþ þþþ þ
Pancytokeratin CAM5.2 Becton Dickinson Co. CA,
USA
þþþ þþþ þþ
CK5/6 D5/16 Dako – þþ –
CK7 N1626 Dako þþ þ –
CK8 35bH11 Dako þþ þþ –
CK14 LL002 Novocastra, Newcastle
upon type, UK
– – –
CK 18 DC10 Dako þþþ þþþ þþþ
CK 19 RCK 108 Progen, Heidelberg,
Germany
þþ þþ –
CK20 K20.8 Dako – – –
TTF-1 8G7G3/1 Dako – – –
Surfactant Apo
A
PE10 Dako – – –
EMA E29 Dako þ þ –
CEA polyclonal Dako þ þ –
p53 protein DO-7 Dako – – –
Ki-67 MIB-I Dako 20% 30% 5%
Chromogranin DAK-A3 Dako – – þþ
Synaptophysin Polyconal Dako – – þþþ
CD56 UJ13A Dako – – þ
KIT polyclonal Dako – – –
PDGFRA Polyclonal Santa Cruz, CA, USA þ þ þ
Adeno, adenocarcinoma. Squamous, squamous cell carcinoma. Small, small cell
carcinoma.þþþ: 67–100% positive.þþ: 33–66%.þ: 1–33% positive.: negative. CK,
cytokeratin. TTF-1, thyroid transcriptional factor-1. EMA, epithelial membrane
antigen. CEA, carcinoembryonic antigen.
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ciation with the adenocarcinoma and squamous cell carcinoma
element. In the cirrhotic livers, metastases of only small cell
carcinoma element were recognized. These different metastatic
sites and route also strongly suggest that the small cell carcinoma is
a different clone, and the adenocarcinoma and squamous cell
carcinoma elements belong to another different clone.
A full review of the literature of pulmonary combined carcinoma
revealed 19 papers. Hashimoto et al.6 reported a case of tumor
composed of small cell carcinoma and well differentiated papil-
lotubular adenocarcinoma. Nomori et al.7 mentioned combined oar
cell carcinoma. Humpherey et al.8 reported 8 cases of pulmonary
carcinomawith a sarcomatoid element. Yokose et al.9 reported that
of 34 small cell lung carcinoma, 12 cases of mixed small cell
carcinoma and 4 cases of combined small cell carcinoma. Hir-
oshima et al.10 reported a combined carcinoma composed of
adenocarcinoma and spindle cell carcinoma. Tsubota et al.11
reported a combined small cell carcinoma and spindle cell carci-
noma. Yang12 reported a combined carcinoma composed of small
cell carcinoma and large cell carcinoma. Chetty13 reported two
cases of combined large cell neuroendocrine carcinoma, small cell
carcinoma, and squamous cell carcinoma. Khalifa et al.14 reported
a case of combined large cell neuroendocrine carcinoma andFig. 9. Brain metastasis shows small cell carcinoma. HE, x200.spindle cell carcinoma. Shikata et al.15 reported a combined carci-
noma consisting of small cell carcinoma, adenocarcinoma, and
squamous cell carcinoma. This case is similar to the present case.
Nicholson et al.16 examined 100 surgical cases of small cell lung
carcinoma, and surprisingly described that 28 cases (28%) showed
combinations with non-small lung carcinoma, with large cell
carcinoma the most common, followed by adenocarcinoma and
squamous cell carcinoma. Murase et al.17 reported 6 cases of
combined small cell and non-small cell carcinoma; three were
small cell carcinoma and squamous cell carcinoma, and the other
three were small cell carcinoma and adenocarcinoma. They found
LOH loci were found in combined small cell and squamous cell
carcinoma, while they were no recognized in combined small cellFig. 10. CEA was expressed in both adenocarcinoma and squamous cell carcinoma
elements. X 200.
Fig. 11. CK5/6 expression is seen in the squamous cell carcinoma element, but not seen
in adenocarcinoma element. X200.
Fig. 13. Small cell carcinoma express element synaptophysin. x200.
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and squamous cell carcinoma has a close clonal relationship, while
the combined small cell and adenocarcinoma does not. Gotoh
et al.18 reported a case of combined carcinoma composed of small
cell carcinoma, spindle cell carcinoma, and squamous cell carci-
noma. Zhang et al.19 described the distinction between small cell
carcinoma and poorly differentiated squamous cell carcinoma and
reported two cases of combined small cell carcinoma and poorly
differentiated squamous cell carcinoma. Hsiano et al.20 reported
a case of combined small cell carcinoma, adenocarcinoma and
spindle cell carcinoma with soft tissue metastases. Michal et al.21
reported two cases of primitive small cell tumor with epithelial,
ganglyocytic, neuroendocrine, and mesenchymal differentiation.
Fellegara et al.22 reported a combined small cell lung carcinoma,
large cell neuroendocrine carcinoma, and adenocarcinoma, and
suggested a monoclonal origin from pluripotent precursor cells
with the use of LOH analysis. Wagner et al.23 reported 7 cases of
combined small cell carcinoma, and performed LOH analyses. They
showed that immunophenotypes were the same between small
and non-small cell carcinomas in 6 patients, and indicated that LOH
shared loss of least 1 marker in every lesion in 5 tumors. Their data
suggest a clonal origin of combined small cell carcinoma of the
lung. These papers indicated no particular tendency of theFig. 12. Small cell carcinoma element express cytokeratin 18. x200.histological types in combined lung carcinoma. However, small cell
carcinoma element and spindle cell carcinoma element are rela-
tively frequent. The origin of the combined is obscure, but recently
molecular studies have begun to disclose the clonality of combined
pulmonary carcinoma. The study is in the state of a start line.
In the present study, AE1/3 and CAM5.2 were expressed in the
three components, indicating that they are epithelial malignancies.
CK5/6 was expressed only in the squamous cell component. It is
reported that CK5/6 is expressed mesothelioma, squamous cell
carcinoma, and other malignancies, but not in adenocarcinoma and
small cell carcinoma.25 CK7 and CK20 patterns are well recognized.
The lung adenocarcinoma and squamous cell carcinoma shows
a CK7-positive and CK20-negative pattern,26,27 as is the case of the
present case. Camilo et al.28 reported that CK7 was expressed in
pulmonary adenocarcinoma in 94% while in pulmonary squamous
cell carcinoma in 7%. In the present study, CK 7 is equally expressed
in adenocarcinoma and squamous cell carcinoma element. CK 14 is
known to express esophageal and pulmonary squamous cell
carcinoma, but the present case was negative for CK 14 in both
adenocarcinoma and squamous cell carcinoma elements.29 Little is
known in the expression of CK8, CK18, and CK19 in lung carci-
noma.30 Scarpatetti et al.30 reported conﬂicting heterogenous
expression of these CK in pulmonary carcinomas. Young et al.31
reported that CK18 was frequently expressed in pulmonary
adenocarcinoma, while it is infrequent pulmonary squamous cell
carcinoma. The present case showed that both adenocarcinoma
and squamous cell carcinoma elements were positive for CK8,
CK18, and CK19, suggesting that pulmonary adenocarcinoma and
squamous cell carcinoma express CK 8, CK18, and CK19. TTF-1 and
PE10 (an antibody to surfactant apoprotein A) are well known
antigens of lung adenocarcinoma.29,32 The percentage of TTF-1
expression of lung adenocarcinoma is 72%,31 and that of PE10 is
27%.29 In the present case, expression of TTF-1 and PE10 were
absent in adenocarcinoma, squamous cell carcinoma, and small cell
carcinoma elements. Leversha et al.33 reported that p53 protein is
expressed in pulmonary adenocarcinoma in 67% and in pulmonary
squamous cell carcinoma in 53%. In the present case, p53 protein
was absent in all the three elements. Little is known about the CK
expression in small cell lung carcinoma. Shumidt et al.34 reported
that small cell lung carcinoma was labeled with pancytokeratin
cocktail but not with CK20, While Hanly et al.35 reported that CK
was expressed in 33% of small cell lung carcinoma. Probably, CK
expression of small cell lung carcinoma is heterogenous, and varies
from case to case. In the present case, the small cell carcinoma
element was positive for AE1/3, CAM5.2 and CK18 (very strong
T. Terada / Respiratory Medicine CME 3 (2010) 246–251 251expression), while was negative for CK5/6, CK7, CK14, CK19 and
CK20. The very strong expression of CK18 in the present study is
interesting. Much more studies CK proﬁles in small cell lung
carcinoma are mandatory. Although most of small cell lung carci-
noma expresses KIT and PDGFRA,36,37 the small cell carcinoma
element of the present case did not express KIT. PDGFRA expression
in the adenocarcinoma and squamous cell carcinoma in the present
case is interesting, and more studies are required.
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